• Press Releases • Videos • Articles • Conferences • Workshops & Webinars

Time News Release

PORTRAIT® PSR3 BY RHYTEC NAMED IN TIME MAGAZINE’S 2006 SKIN TECHNOLOGY STORY

FDA cleared Portrait® PSR3 recognized as one of top new skin care technologies of 2006

New York, NY (November 8, 2006) TIME Magazine has named the FDA cleared Portrait® PSR3 device as one of the top new skin care technologies of 2006 in its November 6th article entitled “Buying a New Face.”

Portrait® PSR3 delivers nitrogen plasma (a highly energized gas) energy, which works both at and below the surface of the skin to modify the skin’s architecture and generate new collagen. The skin’s outer layers remain intact and act as a protective cover until new skin regenerates. Once this happens, the old skin peels away taking with it all the signs of years of exposure to the sun, including brown sun spots and actinic keratoses (rough-textured patches or lesions that form on the outermost layer of the skin), fine lines and deep wrinkles. Additionally Portrait® has profound sustainable cosmetic effects on skin tone, texture and laxity. All of these conditions are treated simultaneously—a unique and significant advantage that distinguishes Portrait® from other cosmetic skin treatments.

This in-office procedure takes 20 – 30 minutes for a full face or body treatment. Localized procedures around the mouth and eyes can be done in as little as 10 to 15 minutes.

Mark Goble, MD, Chief Executive Officer and founder of Rhytec, Inc. commented, “Our Portrait Plasma Skin Regeneration system is a uniquely versatile technology that can be optimized to meet patient expectations in the treatment of a variety of cosmetic indications. Doctors currently using Portrait® PSR3 include Drs. Richard Fitzpatrick, Roy Geronemus, Suzanne Kilmer, Ron Moy, Jeffrey Dover and Doris Day.

About Rhytec:

Rhytec develops innovative plasma technologies based on sound scientific and clinical research for the dermatological, plastic and cosmetic surgery markets. Plasma energy stimulates a true skin regenerative process that is supported by 30 completed and ongoing clinical trials. Founded in 2004, Rhytec works with leading plastic surgeons, dermatologists and cosmetic physicians to develop new technologies that enhance the skin’s appearance and function in order to improve the quality of life for patients seeking treatment. Rhytec, Inc. is privately held, based in Waltham, MA (US) and is a subsidiary of Rhytec, Ltd. in Berkshire (UK).